Notably, our study is the first to demonstrate the prognostic significance of IDH1 mutation in patients with oligodendroglioma or oligoastrocytoma, but not in patients with astrocytoma. The gene discussed is IDH1; the disease is astrocytoma (excluding glioblastoma).